Skip to main content

ARQT

Arcutis Biotherapeutics, Inc.

Company with tickers: ARQT

CIK
1787306
CUSIP
03969K108
Shares Outstanding
125,083,374
13F Activity (30d)
4 filings 3 filers

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Todd Franklin Watanabe $7,223,065
Todd Edwards $3,030,337
Patrick Burnett $3,016,508
Masaru Matsuda $2,118,203
David Topper $1,946,733
Latha Vairavan $1,924,780
Fiscal 2024
Executive Total
David Topper $5,311,203
Todd Franklin Watanabe $3,689,491
Patrick Burnett $2,513,050
John Smither $2,102,418
Todd Edwards $1,965,145
Masaru Matsuda $1,737,532
Fiscal 2023
Executive Total
Todd Franklin Watanabe $4,935,266
Patrick Burnett $1,666,345
Todd Edwards $1,657,847
Masaru Matsuda $1,603,149
General Counsel $1,603,149
John Smither $1,036,225
Fiscal 2022
Executive Total
Masaru Matsuda $5,142,764
General Counsel $5,142,764
Todd Franklin Watanabe $4,581,555
Patrick Burnett $1,584,078
Kenneth Lock $1,270,018
Scott Burrows $1,246,136
Fiscal 2021
Executive Total
John Smither $6,250,292
Todd Franklin Watanabe $4,284,123
Matthew R. Moore $3,794,104
Scott Burrows $2,080,377
Patrick Burnett $1,671,128
Chief Commercial $1,564,381
David W. Osborne $1,555,578
Fiscal 2020
Executive Total
Patrick Burnett $6,849,044
Todd Franklin Watanabe $2,750,883
Chief Commercial $1,267,692
Kenneth Lock $1,267,692
Fiscal 2019
Executive Total
Todd Franklin Watanabe $1,140,296
Chief Commercial $766,075